Abstract
The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 458-460 |
| Number of pages | 3 |
| Journal | Nature Reviews Gastroenterology and Hepatology |
| Volume | 15 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2018 Aug 1 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Fingerprint
Dive into the research topics of 'Gastric cancer: evidence boosts Helicobacter pylori eradication'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS